Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Verve Therapeutics, Inc. (VERV)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 80,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Verve Therapeutics is a genetic medicines company developing an approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. Co.'s primary product candidate, VERVE-101, is designed to turn off the PCSK9 gene in the liver. PCSK9 is a validated target that plays a critical role in controlling blood low-density lipoprotein cholesterol through its regulation of the low-density lipoprotein receptor. Co.'s second program is designed to turn off the ANGPTL3 gene in the liver. ANGPTL3 is a main regulator of cholesterol and triglyceride metabolism.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,800,000 1,800,000 1,810,000
Total Buy Value $0 $18,000,000 $18,000,000 $18,121,526
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 1 2
Total Shares Sold 1,514 2,068 2,068 1,570,794
Total Sell Value $12,475 $18,818 $18,818 $35,262,071
Total People Sold 1 2 2 7
Total Sell Transactions 1 2 2 35
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 99
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Alphabet Inc. Member of 10% Group   –       –      –    2022-11-01 4 AS $36.69 $2,351,706 I/I (63,926) 4,386,850     -
   Alphabet Inc. Member of 10% Group   –       –      –    2022-11-01 4 AS $0.00 $0 I/I (31,963) 6,235,245     -
   Yeshwant Krishna Director   –       •       •   2022-10-31 4 AS $37.91 $2,074,643 I/I (53,696) 4,418,813     -
   Yeshwant Krishna Director   –       •       •   2022-10-31 4 AS $0.00 $0 I/I (53,697) 6,267,208     -
   Alphabet Inc. Member of 10% Group   –       –      –    2022-10-31 4 AS $37.91 $4,149,325 I/I (107,393) 4,418,813     -
   Alphabet Inc. Member of 10% Group   –       –      –    2022-10-31 4 AS $0.00 $0 I/I (53,697) 6,267,208     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-10-28 4 AS $39.90 $399,000 D/D (10,000) 6,629     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-10-28 4 OE $1.48 $14,800 D/D 10,000 16,629     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-10-03 4 AS $33.02 $1,682,622 D/D (50,000) 317,839     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-10-03 4 OE $1.39 $69,500 D/D 50,000 367,839     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-09-23 4 AS $34.67 $2,120,392 D/D (60,000) 6,629     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-09-23 4 OE $1.48 $88,800 D/D 60,000 46,629     -
   Ashe Andrew D. See Remarks   •       –      –    2022-08-25 4 OE $1.39 $152,217 D/D 95,787 266,509     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-08-10 4 AS $29.90 $1,495,000 D/D (50,000) 317,839     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-08-10 4 OE $1.39 $69,500 D/D 50,000 367,839     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-07-20 4 AS $34.90 $698,000 D/D (20,000) 6,629     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-07-20 4 OE $1.39 $27,800 D/D 20,000 26,629     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-07-19 4 AS $29.90 $1,495,000 D/D (50,000) 317,839     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-07-19 4 OE $1.39 $69,500 D/D 50,000 367,839     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-07-13 4 AS $24.90 $249,000 D/D (10,000) 6,629     -
   Bellinger Andrew CSO & CMO   •       –      –    2022-07-13 4 OE $1.48 $14,800 D/D 10,000 16,629     -
   Fmr Corp See Remark 1   –       –       •   2022-07-12 4 S $19.98 $3,386,520 I/I (163,000) 570,729     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-07-07 4 GA $0.00 $0 I/I 160,000 240,997     -
   Kathiresan Sekar Chief Executive Officer   •       •      –    2022-07-07 4 GD $0.00 $0 D/D 160,000 317,839     -
   Fmr Corp See Remark 1   –       –       •   2022-07-01 4 S $15.66 $607,217 I/I (38,775) 773,729     -
  99 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us